Essential Strategies for Optimizing the Use of Long-Acting Treatments in Schizophrenia

Long-acting injectable antipsychotics (LAIs) offer a vital opportunity to improve treatment continuity and outcomes in schizophrenia, yet they remain underutilized in clinical practice. This unique, interactive session combines didactic learning with hands-on practice preparing, and administering LAIs, role-play simulations to improve motivational interviewing skills, and self-paced learning, all designed to enhance treatment and improve patient outcomes.

Supported by an educational grant from Teva Pharmaceuticals, USA, Inc.